It is only available as a research compound
It was first characterized by Predrag Sikiric and colleagues at the University of Zagreb in the early 1990s, and a 2025 literature and patent review cataloged its effects across gastrointestinal, musculoskeletal, and neural models
Nhng lu cn thit khi s dng Ni dung bi vit Glutathione c bit n l mt thnh phn t nhin trong c th con ngi, mang li nhiu li ch cho sc khe
All these can be its modulatory effects, interaction with several molecular pathways [8,11,75,115,116,117,118,119,120,121,122,123], in particular with NO-system [121,122,123,124,125,126,127,128,129,130] as a whole, given the BPC 157/NO-system interaction in controlling blood pressure by a particular mechanism [124,125]